Tixagevimab

(Synonyms: AZD8895; COV2-2196)
Customer Review

Based on 1 Customer Validation

Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor.

For research use only. We do not sell to patients.

  • Purity: 99.05%
  • CAS No.: 2420564-02-7
  • Molecular Weight:146.48 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00